Article
HDAC4 Inhibitors as Antivascular Senescence Therapeutics
Oxidative Medicine and Cellular Longevity · 2022 · Chuoji Huang, author Zhongxiao Lin, author Xiaoyan Liu, author Qian Ding, author Jianghong Cai, author Zhongyi Zhang, author Peter Rose, author Yi Zhun Zhu, author Milena Georgieva, Academic Editor
Key facts
| Title | HDAC4 Inhibitors as Antivascular Senescence Therapeutics |
|---|---|
| First author | Chuoji Huang, author Zhongxiao Lin, author Xiaoyan Liu, author Qian Ding, author Jianghong Cai, author Zhongyi Zhang, author Peter Rose, author Yi Zhun Zhu, author Milena Georgieva, Academic Editor |
| Journal | Oxidative Medicine and Cellular Longevity |
| Published | Mar 19, 2022 |
| DOI | 10.1155/2022/3087916 |
| Devices mentioned | 012419 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1